GCAT is ubiquitously expressed in the pancreas and prostate and is overexpressed in uterine corpus endometrial carcinoma, PRAD, lung adenocarcinoma/squamous carcinoma, invasive breast carcinoma, and colon adenocarcinoma. Here, GCAT is linked to invasive breast carcinoma.